Sabine Schmid Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

12/2010

Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabine Schmid Research Topics

Disease

8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2017
8	Neoplasms (Cancer) 01/2023 - 12/2010
5	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 10/2018
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2022 - 12/2017
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2017
1	Skin Neoplasms (Skin Cancer) 05/2023
1	Melanoma (Melanoma, Malignant) 05/2023
1	Circulating Neoplastic Cells 12/2022
1	Brain Neoplasms (Brain Tumor) 05/2022
1	Adenocarcinoma 05/2022
1	Yellow Fever 09/2020
1	Rheumatic Diseases (Rheumatism) 09/2020
1	Frailty 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Disease Progression 09/2019
1	Breast Neoplasms (Breast Cancer) 09/2019
1	Malignant Mesothelioma 11/2018
1	Inflammation (Inflammations) 01/2017
1	Disease Susceptibility (Diathesis) 01/2016
1	Rickettsia Infections 06/2013
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 06/2013
1	Babesiosis (Piroplasmosis) 06/2013
1	Anaplasmosis 06/2013
1	Tick-Borne Diseases (Tick-Borne Disease) 06/2013
1	Edema (Dropsy) 12/2010
1	Meningioma (Meningiomas) 12/2010
1	Bites and Stings (Sting) 05/2009
1	Malaria 05/2009

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 01/2022 - 05/2018
3	NivolumabIBA 05/2023 - 01/2017
2	pembrolizumabIBA 05/2023 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
2	abirateroneIBA 01/2020 - 01/2019
1	AntibodiesIBA 05/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	larotrectinibIBA 01/2023
1	tropomyosin kinaseIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Cell-Free Nucleic AcidsIBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2022
1	sotorasibIBA 05/2022
1	C-Reactive ProteinIBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	binimetinibIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020
1	PlatinumIBA 10/2020
1	Methotrexate (Mexate)FDA LinkGeneric 09/2020
1	osimertinibIBA 01/2020
1	enzalutamideIBA 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 09/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	RadiumIBA 10/2018
1	Radium-223IBA 10/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	Ferritins (Ferritin)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2016
1	VaccinesIBA 06/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010

Therapy/Procedure

6	Therapeutics 05/2023 - 01/2019
3	Immunotherapy 01/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 10/2020 - 09/2019
3	Castration 10/2020 - 10/2018
1	Time-to-Treatment 01/2023
1	Aftercare (After-Treatment) 01/2020
1	Radiotherapy 12/2017
1	Chemoprevention 05/2009